Explore more publications!

New computational tool helps scientists interpret complex single-cell data

Figure: Illustration highlighting the difference between analysing single-cell data without or with integration. Credit: Laura Elo

Researchers have developed a new computational method to interpret complex single-cell data. The method, Coralysis, is available as an open-source software.

Coralysis provides the scientific community with a new way to study cellular diversity and gain a deeper understanding of complex single-cell data.”
— Professor Laura Elo
TURKU, FINLAND, November 17, 2025 /EINPresswire.com/ -- Researchers from Turku Bioscience Centre at the University of Turku, Finland, have developed a new computational method to interpret complex single-cell data. The method helps researchers identify and group cell types across samples.

The human body contains about 37 trillion cells. Some are more alike than others, yet never exactly the same. Modern single-cell technologies allow characterising this cellular heterogeneity, measuring dozens to thousands of molecules, such as genes or proteins, across thousands of individual cells simultaneously and providing insights into health and diseases.

A small amount of blood contains billions of red blood cells and millions of immune cells. Each type of cell has its own molecular ‘fingerprint’, which researchers can identify by combining single-cell technologies with computational methods.

When studying several different samples, scientists must first match the same cell types across the samples. This is a demanding step known as data integration.

However, current integration methods often struggle when cell types vary between samples or appear in very different amounts. In such cases of imbalanced data, methods can mistakenly combine distinct cell types.

To solve this, researchers from the University of Turku have now developed a new machine learning-based algorithm that effectively integrates even imbalanced data across samples. The method, called Coralysis, has been developed at Turku Bioscience Centre in Professor Laura Elo’s Computational Biomedicine research group, which is also affiliated with the InFLAMES Research Flagship.

“Single-cell technologies let us study the incredible diversity of cells, but comparing them across samples is tricky. This motivated us to develop a method to uncover these hidden patterns reliably,” says Associate Professor Sini Junttila, one of the supervisors of the study.

Effective open-source tool

“We were inspired by the process of assembling a puzzle, where one begins by grouping pieces based on low- to high-level features, such as colour and shading, before looking at shape and patterns. Similarly, our algorithm progressively integrates cellular identities through multiple rounds of divisive clustering,” explains Doctoral Researcher António Sousa, the lead developer of Coralysis.

Coralysis has been implemented as an open-source software. At its core, it relies on machine learning, enabling it to build models that can be used to predict cellular identities in new datasets and even estimate how confident the predictions are. This helps researchers avoid the cumbersome and often unreliable task of manually identifying cell types. Another unique feature of Coralysis is its ability to detect changing cellular states that might otherwise be missed.

“Coralysis provides the scientific community with a new way to study cellular diversity and gain a deeper understanding of complex single-cell data. By making it openly available, we hope to support collaboration and accelerate discoveries across the global research community,” says Professor Laura Elo, the principal investigator of the project.

The study by Elo’s research group has been published in the scientific journal Nucleic Acids Research.

Tuomas Koivula
University of Turku
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions